RSC-BMCS/SCI Targeting Protein Degradation 5

Event
RSC-BMCS/SCI Targeting Protein Degradation 5

Dates
21st October- 22nd October, 2026

Place
The Fielder Centre, Hatfield

Important links
Social media hashtag – #ProtDeg26

Synopsis
One of the most exciting new therapeutic modalities to emerge in the 21st century has been Targeted Protein Degradation (TPD). In 2021, the Targeted Protein Degradation Market size was valued at USD 400.5 million and is poised to grow from USD 507.0 million in 2022 to USD 3,300.0 million by 2030 and so has attracted interest from academia, non-profit organisations through to CROs and small and large pharma.

This multidisciplinary meeting aims to present the latest developments in the design, biology, chemistry and ADME in TPD within the general themes of PROTACS (including non-oncology targets), Molecular Glues and non-PROTAC degraders. We aim to highlight the newest in enabling technologies such as computational techniques, Direct to Biology, HT synthesis (click, photochemistry etc) and structural biology methods.

Who should attend
The meeting aims is targeted at academic and industrial scientists engaged in all aspects of research into the ubiquitin proteasome pathway and those interested in broadening their knowledge in this rapidly expanding field.

Registration
Registration will be open soon, check back for further details.

Call for Abstracts
Abstract submission will be open soon, check back for further details.

Sponsorship and Exhibitors
Registration will be open soon, check back for further details. If you would be interested in sponsoring or exhibiting at this event, please contact events@hg3.co.uk.

Organising Committee
Sean Bew, UEA
A Ganesan, University of East Anglia
Katherine Jones, Charles River (Chair)
Jayshree Mistry
Suzanne O’Connor, University of Dundee
Hannah Woodward, MSD (Treasurer)